Rumana Haque-Ahmed

Rumana Haque-Ahmed has significant work experience in the field of regulatory affairs. Currently, they hold the position of Vice President Regulatory Affairs at Taysha Gene Therapies, starting in March 2021. Prior to this role, they worked at Sanofi where they held various leadership positions in regulatory affairs. Their roles at Sanofi included Head of International, Regulatory Affairs from April 2020 to March 2021, Head of Regulatory Affairs - Asia from May 2016 to April 2020, AVP Regulatory Affairs, Global Therapeutic Head, Rare Diseases from November 2014 to April 2020, and Senior Director Regulatory Affairs from February 2008 to November 2014. Before joining Sanofi, they worked at idenix pharmaceuticals as Sr. Director, regulatory affairs from February 2001 to 2008. Earlier in their career, they held the position of manager regulatory affairs at Curis, Inc from 2001 to 2002, and worked in regulatory affairs at Genzyme from 1998 to 2000. Their regulatory affairs career began at Parexel where they worked from August 1994 to August 1997.

Rumana Haque-Ahmed attended Memorial University of Newfoundland from 1988 to 1993. The specific degree and field of study are not provided.